Newronika logo Building Brain Computers

Building Brain Computers

We translate basic research into clinical practice with the aim of improving treatments, health, and wellness

Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life.
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​
Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Quality System

Newronika Quality Management System ensures proper implementation and effective monitoring of design, development, purchasing, production, marketing, customer communication, and assistance processes. The implementation and maintenance of the Quality Management System represents the way Newronika has worked since the company started. The application of the Quality Management System ensures that the products comply with regulatory and custom requirements.

The Products are designed and manufactured in accordance with the European Directive 93/42/EEC and 90/385 on medical devices and meet the requirements of harmonized standards that apply to them. Requirements set by Canadian MDR and South Korea are also comply with. 

The certification of conformity to the ISO 13485 has been released by authorities in the EU, Canada, and South Korea.

Shareholders

2 Public Institutions
3 Venture Capital

The 13 Founders from Polyclinic and University of Milan: Neurosurgeons, Neurologists, Bioengineers, Neuropsychologists, Biotechnologist, Neurophysiology Technicians.



News room
Neuromodulation Therapy Developer Newronika Raises €1.7M in Venture Capital
14/06/2016
1.7 million for startup that fights Parkinson's
14/06/2016
Innogest, Intesa Sanpaolo and F3F invest 1.7 million in Newronika
14/06/2016
Intesa Sanpaolo: In the pool a loan of 1.7 mln to Newronika
14/06/2016
First funding of 1.7 million for Newronika, the start up of medical device
14/06/2016
Innogest and Intesa invest 1.7M in Newronika (Deep Brain Stimulation)
14/06/2016
Intesa Sanpaolo: Atlante Ventures co-invest in Newronika
14/06/2016
Eight-hours adaptive deep brain stimulation in patients with Parkinson disease
13/03/2018
Board of Directors
Laura Iris Ferro
President
Lorenzo Rossi
CEO
Alberto Priori
Board member
Claudio Rumazza
Board member
Sergio Barbieri
Board member
Scientific Board
Alberto Priori
Coordinator
Andrès Lozano
Member
Elena Moro
Member
Jens Volkmann
Member
Sara Marceglia
Facilitator
Management
Lorenzo Rossi
CEO
Fabio Grisoni
Chief Strategic Officer
Alain Garcinuño
CFO, Investors Relations Business Development
Work with us

Working with us means a dynamic environment, geared towards the future of new technologies in neuromodulation. Our team comprises neurophysiology technicians, biotechnologists, neurologists and neurosurgeons, pshychologists, and engineers. If you are interested in internship or you want to be part of our team, send us your CV.

submit your cv
key